Adventures in eMarketing

Welcome to the Summer edition of Siren Interactive's newsletter, Adventures in eMarketing.

You may have heard about the recent FDA Letter to Novartis on the Facebook Share widget. However, the letter wasn’t really about Facebook or social sharing widgets, but a lack of fair balance. It was the message not the medium. The content in the Facebook Share widget was pulled from the website’s metadata. To learn more read What’s Metadata & Why Pharma Should Care.

Additionally, Siren’s Director of Search & Innovation, Eileen O’Brien, was quoted in the ClickZ article on this topic: Pharma on Facebook: FDA Cites Novartis Violations.

If you have questions or would like to learn more, please feel free to contact us.

Top SirenSong Blog Entries

•	FDA Letter to Novartis on Facebook “Share This” icons and widgets are becoming more and more common on websites. In our unique industry, we must be careful about what we share…and what we don’t.
•	Google Starts Editing Drug Results Is the popular search engine moving away from neutrality?
•	Crossing the Chasm of Pharma Social Media Adoption No more timid tip-toeing – the pharma marketing industry has cleared the chasm. Now brace yourself for the oncoming social media tornado…
•	What’s Foursquare & Why Should I Care? All you need to know about Foursquare and other location-based technology.
•	CRM Basics: Know Your Audience & Test, Test, Test! One email mishap could lead to disaster – or maybe not. It depends on YOUR audience.
•	Don’t Forget the CRM Basics: Timing is Everything Coffee and the Chicago Blackhawks: timely, relevant content reaps big eMarketing rewards.

Event Highlight

Wendy White, Founder & President of Siren, will be speaking at the ePatient Connections seminar in Philadelphia, PA. The event will be September 28-29, 2010. For a $300 discount, use the code SIREN300 on registration.

Siren News

Siren is a finalist for the Medical Marketing & Media (MM&M) Award for “Best Use of Social Media” for its work with the National Organization for Rare Disorders to promote Rare Disease Day.

Eileen O’Brien, Director of Search Innovation, was quoted in the ClickZ article: Pharma on Facebook: FDA Cites Novartis Violations.

MY READING LIST

•	Patients Can Have Greater Influence on Success, Failure of New Drugs, Quintiles Report Reveals Forbes
•	SlideShare Announces Pfizer is First Company in Regulated Industry to Launch Social Media Channel on its Platform Forbes
•	U.S. Drug Prices Aren't Sky-High, Study Finds FiercePharma
•	Linguistics Professor Examines Manufacturers' Prescription Drug Websites ScienceDaily
•	Mobile Pill Cap Takes Social Approach to Raising Compliance Medical Marketing & Media
•	Women on the Web: How Women are Shaping the Internet comScore
•	Email Drives Social Networking MarketingCharts
•	DDMAC Regulatory Letters Could Double in 2010 Medical Media & Marketing
•	How Health Info Seekers Harness the Web eMarketer
•	New FDA Basics Video Available about Orphan Drugs and the Fight Against Rare Diseases FDA Transparency Blog
•	What Makes Social Media Trustworthy? eMarketer

Research Insight: Consumer Reaction to DTC Advertising of Prescription Drugs

Prevention magazine released their 13th annual national survey Consumer Reaction to DTC Advertising of Prescription Drugs which provides more proof that people go to social media with their health concerns. According to the survey (phone interviews of 1,501 adults) 60% of online consumers use social media. User-generated sites such as Wikipedia and online forums such as PatientsLikeMe.com had a following of 42% (both up 6% over last year), while health-related blogs like Rateadrug.com were at 30% (up 3%).

Online consumers want to obtain information from

Consumers are online seeking


	This email was sent by: Siren Interactive Corp. 1100 Lake Street, Suite 140 Oak Park, IL, 60301, 708-763-0763